Heart Test Laboratories Inc (HSCS)

$3.24 -0.13 (-3.86%)
Market Cap 2.27M
Revenue (ttm) 20,000.00
Net Income (ttm) -6.61M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 11,938
Avg Vol 455,542
Day's Range N/A - N/A
Shares Out 656,000.00
Stochastic %K 24%
Beta 3.16
Analysts Strong Sell
Price Target $13.50

Company Profile

HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventi...

Industry: Medical Devices
Sector: Healthcare
Phone: 682 237 7781
Address:
550 Reserve Street, Suite 360, Southlake, United States
TheUnmaker
TheUnmaker Mar. 19 at 4:07 PM
$TNXP I'm waiting for my $GRAL type run on this. Ran $GRAL from under $30 to $115+. I'm considering $HSCS soon also to run through when the time is right. Potential $30 squeeze play.
0 · Reply
DrTampa
DrTampa Mar. 18 at 5:30 PM
$HSCS only 533 shares traded by 12:30 😂😂
0 · Reply
TheUnmaker
TheUnmaker Mar. 18 at 12:43 AM
$HSCS reloading.. we are back in the demand zone.
0 · Reply
ByBi
ByBi Mar. 17 at 10:45 PM
$TNXP $GRAL $HSCS $BCDA Agreed. Tnxp long term downtrend reversing seem here. This swing trade heading to low 100's if it does. One of the best 2026 potential out there imo. 👀👀👀
1 · Reply
TheUnmaker
TheUnmaker Mar. 17 at 8:49 PM
$TNXP If you connect a descending trend line from the top of the candle on 12/17/24 and connect it to the top of the candle on 8/14/25 you will see that it descends down to todays top price. Between $12.80 and $15.45 is a strong demand zone. We are nearing a breakout if this buying zone remains. I want my $59 gap fill. Loading for the long haul on this sleeper! $GRAL $HSCS $BCDA
0 · Reply
DrTampa
DrTampa Mar. 16 at 8:28 PM
$HSCS 10-K has dropped! https://s3.amazonaws.com/sec.irpass.cc/2729/0001437749-26-008399.htm
0 · Reply
DrTampa
DrTampa Mar. 16 at 8:03 PM
$HSCS drop the 10-k Simpson!
0 · Reply
Moneyybaggs
Moneyybaggs Mar. 16 at 12:28 PM
$HSCS So 3Q ER must drop either today or tomorrow in order to satisfy the 45-day requirement. Need Simpson to provide some serious guidance and announce some nice revenue generating contracts.
0 · Reply
Rampagee
Rampagee Mar. 16 at 12:27 PM
$HSCS
0 · Reply
Moneyybaggs
Moneyybaggs Mar. 16 at 12:01 PM
$HSCS I’m right there with you DT!!! It’s time for some explosive fireworks from HSCS!!! You’ve left me in the dust. My position is a paultry 127K shares!!!🤪🤪🤪 LFGOOOOOOOOOO SIMPSON!!!
1 · Reply
Latest News on HSCS
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

Mar 16, 2026, 4:15 PM EDT - 5 days ago

HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

University of West England Adopts HeartSciences' MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center

Feb 5, 2026, 8:30 AM EST - 6 weeks ago

University of West England Adopts HeartSciences' MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center

Cibolo Health Designates HeartSciences' MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals

Jan 29, 2026, 8:30 AM EST - 7 weeks ago

Cibolo Health Designates HeartSciences' MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals

HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

Dec 15, 2025, 4:15 PM EST - 3 months ago

HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device

Dec 15, 2025, 8:30 AM EST - 3 months ago

HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device

HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1

Dec 11, 2025, 8:30 AM EST - 3 months ago

HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1

HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results

Sep 11, 2025, 4:15 PM EDT - 6 months ago

HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results

HeartSciences Announces Conference Participation and Investor Webinar

Aug 15, 2025, 9:00 AM EDT - 7 months ago

HeartSciences Announces Conference Participation and Investor Webinar

HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results

Jul 24, 2025, 4:15 PM EDT - 8 months ago

HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results

HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis

Jun 4, 2025, 9:00 AM EDT - 10 months ago

HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis

Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value

Jun 3, 2025, 9:00 AM EDT - 10 months ago

Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone

May 29, 2025, 9:00 AM EDT - 10 months ago

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone

HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025

May 20, 2025, 9:00 AM EDT - 10 months ago

HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025

HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson

May 8, 2025, 9:00 AM EDT - 11 months ago

HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson

HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board

May 7, 2025, 9:00 AM EDT - 11 months ago

HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board

HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

May 1, 2025, 9:00 AM EDT - 11 months ago

HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

Mar 13, 2025, 4:15 PM EDT - 1 year ago

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

Mar 10, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

Dec 16, 2024, 4:15 PM EST - 1 year ago

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

Nov 13, 2024, 9:00 AM EST - 1 year ago

HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 14, 2024, 4:15 PM EDT - 1 year ago

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

Sep 12, 2024, 4:15 PM EDT - 1 year ago

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

Sep 12, 2024, 9:00 AM EDT - 1 year ago

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

Jul 29, 2024, 4:05 PM EDT - 1 year ago

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

Jul 26, 2024, 9:00 AM EDT - 1 year ago

Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

Jul 25, 2024, 8:30 AM EDT - 1 year ago

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

Jul 11, 2024, 9:00 AM EDT - 1 year ago

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

HeartSciences Regains Compliance with Nasdaq Listing Requirements

Jun 4, 2024, 4:15 PM EDT - 1 year ago

HeartSciences Regains Compliance with Nasdaq Listing Requirements

HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio

May 20, 2024, 9:00 AM EDT - 1 year ago

HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

Apr 24, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

HeartSciences to Present at the LD Micro Invitational XIV Conference

Apr 2, 2024, 4:15 PM EDT - 2 years ago

HeartSciences to Present at the LD Micro Invitational XIV Conference

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

Mar 26, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

Mar 14, 2024, 4:15 PM EDT - 2 years ago

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

Mar 12, 2024, 9:00 AM EDT - 2 years ago

HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

Mar 6, 2024, 9:00 AM EST - 2 years ago

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

HeartSciences Adds Key Advisor to its Scientific Advisory Board

Feb 26, 2024, 9:00 AM EST - 2 years ago

HeartSciences Adds Key Advisor to its Scientific Advisory Board

HeartSciences Expands its Scientific Advisory Board

Feb 12, 2024, 9:00 AM EST - 2 years ago

HeartSciences Expands its Scientific Advisory Board

HeartSciences Appoints New Scientific Advisory Board Member

Feb 1, 2024, 9:00 AM EST - 2 years ago

HeartSciences Appoints New Scientific Advisory Board Member

HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting

Jan 18, 2024, 8:00 AM EST - 2 years ago

HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting

HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting

Jan 3, 2024, 4:15 PM EST - 2 years ago

HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting

HeartSciences Reports Second Quarter Fiscal 2024 Financial Results

Dec 14, 2023, 4:15 PM EST - 2 years ago

HeartSciences Reports Second Quarter Fiscal 2024 Financial Results

HeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway

Dec 5, 2023, 8:00 AM EST - 2 years ago

HeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway

HeartSciences' MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police Officers

Nov 13, 2023, 8:45 AM EST - 2 years ago

HeartSciences' MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police Officers

Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)

Nov 3, 2023, 8:28 AM EDT - 2 years ago

Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)

ARQT SINT

HeartSciences Reports First Quarter Fiscal 2024 Financial Results

Sep 14, 2023, 4:15 PM EDT - 2 years ago

HeartSciences Reports First Quarter Fiscal 2024 Financial Results

HeartSciences to Present at the Gilmartin Group Emerging Growth Showcase

Sep 12, 2023, 4:15 PM EDT - 2 years ago

HeartSciences to Present at the Gilmartin Group Emerging Growth Showcase

HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence Awards

Sep 11, 2023, 4:15 PM EDT - 2 years ago

HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence Awards

HeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, India

Sep 7, 2023, 9:00 AM EDT - 2 years ago

HeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, India

HeartSciences Signs Distribution Agreement with FJ Medical, Denmark

Aug 31, 2023, 9:00 AM EDT - 2 years ago

HeartSciences Signs Distribution Agreement with FJ Medical, Denmark

HeartSciences' MyoVista® wavECGTM Selected to be used in Irish Heart Screening Evaluation

Aug 24, 2023, 9:00 AM EDT - 2 years ago

HeartSciences' MyoVista® wavECGTM Selected to be used in Irish Heart Screening Evaluation

TheUnmaker
TheUnmaker Mar. 19 at 4:07 PM
$TNXP I'm waiting for my $GRAL type run on this. Ran $GRAL from under $30 to $115+. I'm considering $HSCS soon also to run through when the time is right. Potential $30 squeeze play.
0 · Reply
DrTampa
DrTampa Mar. 18 at 5:30 PM
$HSCS only 533 shares traded by 12:30 😂😂
0 · Reply
TheUnmaker
TheUnmaker Mar. 18 at 12:43 AM
$HSCS reloading.. we are back in the demand zone.
0 · Reply
ByBi
ByBi Mar. 17 at 10:45 PM
$TNXP $GRAL $HSCS $BCDA Agreed. Tnxp long term downtrend reversing seem here. This swing trade heading to low 100's if it does. One of the best 2026 potential out there imo. 👀👀👀
1 · Reply
TheUnmaker
TheUnmaker Mar. 17 at 8:49 PM
$TNXP If you connect a descending trend line from the top of the candle on 12/17/24 and connect it to the top of the candle on 8/14/25 you will see that it descends down to todays top price. Between $12.80 and $15.45 is a strong demand zone. We are nearing a breakout if this buying zone remains. I want my $59 gap fill. Loading for the long haul on this sleeper! $GRAL $HSCS $BCDA
0 · Reply
DrTampa
DrTampa Mar. 16 at 8:28 PM
$HSCS 10-K has dropped! https://s3.amazonaws.com/sec.irpass.cc/2729/0001437749-26-008399.htm
0 · Reply
DrTampa
DrTampa Mar. 16 at 8:03 PM
$HSCS drop the 10-k Simpson!
0 · Reply
Moneyybaggs
Moneyybaggs Mar. 16 at 12:28 PM
$HSCS So 3Q ER must drop either today or tomorrow in order to satisfy the 45-day requirement. Need Simpson to provide some serious guidance and announce some nice revenue generating contracts.
0 · Reply
Rampagee
Rampagee Mar. 16 at 12:27 PM
$HSCS
0 · Reply
Moneyybaggs
Moneyybaggs Mar. 16 at 12:01 PM
$HSCS I’m right there with you DT!!! It’s time for some explosive fireworks from HSCS!!! You’ve left me in the dust. My position is a paultry 127K shares!!!🤪🤪🤪 LFGOOOOOOOOOO SIMPSON!!!
1 · Reply
DrTampa
DrTampa Mar. 16 at 3:55 AM
$HSCS knocking on 150k shares 🤑🤑🤑 earnings will drop this week and we have the annual meeting start of April! Now, can we get some substantial contract news and revenue estimates? That'd be great Simpson!
0 · Reply
DrTampa
DrTampa Mar. 12 at 3:23 AM
$HSCS earnings should be dropping sometime This week or next! hopefully Simpson has some news on revenues or hospital systems that are going to be adopting myovista insights!
0 · Reply
DrTampa
DrTampa Mar. 11 at 11:25 PM
$HSCS got to love the price dip to $2.50 today but funny enough my $2.51 and $2.52 orders did not fill 😐😐 Either way, still been buying and I'm up to 149,000 shares 🫡🫡
1 · Reply
MayaRbt_
MayaRbt_ Mar. 10 at 1:55 PM
$HSCS Illiquid small cap, float rotation key for breakout
0 · Reply
RKLBupupup
RKLBupupup Mar. 9 at 12:20 AM
$HSCS tapping sub to see if anyone still alive down there
1 · Reply
DrTampa
DrTampa Mar. 6 at 6:58 PM
$HSCS another day watching paint dry, but grabbed a few more shares while they still on sale 🫡🤑
0 · Reply
topstockalerts
topstockalerts Mar. 4 at 2:03 PM
Pre Market Top Gainers PT2 $BNAI $SWIM $PRHI $HSCS $MOBX
0 · Reply
topstockalerts
topstockalerts Mar. 4 at 12:07 PM
Pre Market Top Gainers PT2 $BNAI $SWIM $PRHI $HSCS $MOBX
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 4 at 5:26 AM
$HSCS RSI: 19.82, MACD: -0.1080 Vol: 0.17, MA20: 2.93, MA50: 3.03 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
DrTampa
DrTampa Mar. 4 at 4:21 AM
$HSCS March 15th should be earnings, as well as 90 days since FDA submission. Would love to hear more partnership news as well as revenue guidance for 2026!
0 · Reply
DrTampa
DrTampa Mar. 4 at 2:01 AM
$HSCS finally crossed the 146,000 threshold 🫡
0 · Reply
topstockalerts
topstockalerts Mar. 3 at 2:24 PM
Pre Market Top Gainers PT2 $ELOG $HSCS $EHTH $TROO $PLUL
0 · Reply